You can buy or sell CYCC and other stocks, options, ETFs, and crypto commission-free!
Cyclacel Pharmaceuticals, Inc. Common Stock, also called Cyclacel Pharmaceuticals, is a clinical-stage biopharmaceutical company. Read More It uses cell cycle, transcriptional regulation and DNA damage response biology to develop innovative, targeted medicines for cancer and other proliferative diseases. The company builds a diversified biopharmaceutical business, which is focused in hematology and oncology based on a pipeline of novel drug candidates. Its products include CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.
Berkeley Heights, New Jersey
52 Week High
52 Week Low
Yahoo FinanceApr 29
Could Cyclacel Pharmaceuticals, Inc.'s (NASDAQ:CYCC) Investor Composition Influence The Stock Price?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! If you want to know who really controls Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC), then you'll have to look at the makeup of its share registry. Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller companies. Warren Buffett said that he likes 'a business with enduring competitive advantages that is run by able and owner-ori...
-$0.20 per share
-$0.14 per share